|
|
Volumn 89, Issue 4, 2002, Pages 450-452
|
|
Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab
a,b,d
c
Lilly GmbH
(Germany)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CLOPIDOGREL;
CREATININE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HEPARIN;
STATIN;
TICLOPIDINE;
WARFARIN;
ACUTE HEART INFARCTION;
ADULT;
AGED;
BLEEDING;
COMORBIDITY;
CONTROLLED STUDY;
CORONARY ARTERY DILATATION;
CORONARY STENT;
CREATININE BLOOD LEVEL;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HEART MUSCLE ISCHEMIA;
HUMAN;
KIDNEY DYSFUNCTION;
KIDNEY FAILURE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTIVARIATE ANALYSIS;
PRIORITY JOURNAL;
REGISTER;
RISK FACTOR;
SHORT SURVEY;
ST SEGMENT ELEVATION;
THORAX PAIN;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
TREATMENT INDICATION;
TREATMENT OUTCOME;
UNSTABLE ANGINA PECTORIS;
|
|
EID: 0037083099
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(01)02267-6 Document Type: Article |
|
Times cited : (29)
|
|
References (10)
|
